Filtrer vos résultats
- 3
- 1
- 4
- 4
- 1
- 1
- 1
- 1
- 4
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyThe Lancet Rheumatology, 2021, 3 (6), pp.e419-e426. ⟨10.1016/S2665-9913(21)00059-X⟩
Article dans une revue
hal-03365306v1
|
||
|
Spondyloarthritis-Associated IgA NephropathyKidney International Reports, 2020, 5 (6), pp.813-820. ⟨10.1016/j.ekir.2020.03.012⟩
Article dans une revue
hal-02934545v1
|
||
|
Lack of Association between the TNFAIP3 Rs2230926 Variant and Rheumatoid Arthritis-Associated Lymphoma.Joint Bone Spine, 2022, 89 (5), pp.105390. ⟨10.1016/j.jbspin.2022.105390⟩
Article dans une revue
hal-03792023v1
|
||
|
Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO studyDigestive and Liver Disease, 2023, 55 (1), pp.61-68. ⟨10.1016/j.dld.2022.07.012⟩
Article dans une revue
hal-04167918v1
|